[Psychopharmaceuticals in chronic pain]

Area of Science:

• Pharmacology
• Neurology
• Pain Management

Context:

• Chronic and severe pain present significant treatment challenges.
• Traditional analgesics may have limitations, including dependence.
• Psychotropic medications have emerged as valuable therapeutic options.

Purpose:

• To review the role of psychotropic drugs in managing chronic and severe pain.
• To elucidate the mechanisms underlying their analgesic effects.
• To highlight their advantages over traditional pain therapies.

Summary:

• Psychotropic drugs, such as carbamazepine, antidepressants, and neuroleptics, have improved pain treatment.
• They possess analgesic properties, potentiate other analgesics, and crucially, do not cause dependence with long-term use.
• Their efficacy stems from altering central pain perception, effectively depersonalizing pain and interrupting detrimental pain-related psychological cycles.
• Antidepressants modulate serotonin and noradrenaline pathways, while some neuroleptics exhibit opiate receptor binding and agonistic effects, contributing to pain inhibition.

Impact:

• These findings underscore the importance of psychotropic medications in multimodal pain management strategies.
• They offer a viable alternative for patients with chronic pain, particularly those at risk of dependence.
• Further research into neurochemical pathways can optimize psychotropic drug use for pain relief.